Wuhan Hvsen Biotechnology Co (SZSE:300871) Ending Cash Position : ¥152 Mil (As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Wuhan Hvsen Biotechnology Co Ending Cash Position?

Wuhan Hvsen Biotechnology Co's Ending Cash Position for the quarter that ended in Mar. 2025 was ¥152 Mil.

Wuhan Hvsen Biotechnology Co's quarterly Ending Cash Position increased from Sep. 2024 (¥139 Mil) to Dec. 2024 (¥185 Mil) but then declined from Dec. 2024 (¥185 Mil) to Mar. 2025 (¥152 Mil).

Wuhan Hvsen Biotechnology Co's annual Ending Cash Position declined from Dec. 2022 (¥279 Mil) to Dec. 2023 (¥230 Mil) and declined from Dec. 2023 (¥230 Mil) to Dec. 2024 (¥185 Mil).

Wuhan Hvsen Biotechnology Co Ending Cash Position Historical Data

The historical data trend for Wuhan Hvsen Biotechnology Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuhan Hvsen Biotechnology Co Ending Cash Position Chart

Wuhan Hvsen Biotechnology Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

285.51

966.14

278.61

229.51

184.59

Wuhan Hvsen Biotechnology Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Ending Cash Position	Get a 7-Day Free Trial															201.75	274.44	139.35	184.59	151.85

Wuhan Hvsen Biotechnology Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Wuhan Hvsen Biotechnology Co's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	229.513	+	-44.921
	=	185

Wuhan Hvsen Biotechnology Co's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	184.593	+	-32.745
	=	152

Wuhan Hvsen Biotechnology Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Wuhan Hvsen Biotechnology Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Wuhan Hvsen Biotechnology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Wuhan Hvsen Biotechnology Co Ltd (SZSE:300871) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

218 Zhangbai Road, Dongxihu District, Hubei Province, Wuhan, CHN, 430042

Website

http://www.whhsyy.com

Wuhan Hvsen Biotechnology Co Ltd is engaged in research and development, production and sales of veterinary drugs (including chemical drug preparations, raw materials, and Chinese medicine preparations), feed and additives. It produces tylvalosin raw material, various tylvalosin preparations, florfenicol preparations and other macrolides products.

Wuhan Hvsen Biotechnology Co Headlines

No Headlines